mlsanityData to 14 Oct 2026

A Precedent-Guided Co-Scientist for Side-Effect-Aware Drug Redesign

arXiv 2607.02944 ↗First posted 3 Jul 2026cs.LG cs.AIcited by 0

Not on the map. Why?

Abstract (arXiv)

We propose PRECEDE, a precedent-guided co-scientist for side-effect-aware drug redesign that revises a parent compound to mitigate a specified side effect while preserving therapeutic function. Rather than isolated molecular generation, PRECEDE frames redesign as evidence-grounded reasoning over drug--side-effect associations, biomedical knowledge graphs, and precedents of safety-driven optimization, coordinated by an LLM orchestrator with explicit policies and human-review checkpoints. We position PRECEDE as a human-supervised AI-for-science workflow in which hypotheses remain auditable, falsifiable, and bounded by prior pharmacology.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 4 of its 25 references that are in the map. First posted on arXiv 3 Jul 2026.

Builds on

4 of 25 references.

References · 4

  1. 2025Qwen3 Technical Reportcited by 8,820
  2. 2018Junction Tree Variational Autoencoder for Molecular Graph Generationcited by 652
  3. 2024DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaborationcited by 44
  4. 2025LIDDIA: Language-based Intelligent Drug Discovery Agentcited by 24

Built on by

Not cited yet.